semaglutide patent date Ozempic's Protection Starts to Expire in 2026. What Next? India's Semaglutide Patent Expiry Sparks

References Vaduganathan, M., Mensah, G

This collaborative approach ensures that your transition onto Ozempic is thoughtful, informed, and aligned with your health goals

Future RCTs that are larger and longer-term, along with real-world studies that appropriately involve diverse ethnic groups, are anticipated to enhance our understanding of the oncogenic or anti-oncogenic potential (if any) of tirzepatide

Theoretical concerns based on mechanism include phosphate dysregulation from chronic renal phosphate wasting, potential antibody formation against the peptide sequence with repeated dosing, and unknown reproductive or developmental effects